Cabozantinib With Ifosfamide in Ewing's Sarcoma and Osteosarcoma
Status:
Recruiting
Trial end date:
2028-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to better understand how safe and effective the drug
cabozantinib in combination with high-dose ifosfamide is in the treatment of children and
adults with relapsed/refractory Ewing sarcoma and osteosarcoma.
Phase:
Phase 1
Details
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborators:
Alex's Lemonade Stand Foundation Children's Hospital Colorado Exelixis